Glib-Ratiopharm S

Glibenclamide is an oral medication used to manage type 2 diabetes by lowering blood sugar levels. This Glib-Ratiopharm S variant is manufactured by Ratiopharm Gmbh in the EU.

Glibenclamide is primarily used to control blood sugar levels in adults with type 2 diabetes. It works by stimulating the pancreas to produce more insulin, which helps the body use glucose more effectively. This medication is often prescribed as part of a broader treatment plan that includes diet and exercise. People often ask, 'What is Glibenclamide used for?' and the answer is that it is used to manage diabetes and improve glycemic control.

Common effects of Glibenclamide may include hypoglycemia, or low blood sugar, which can cause symptoms like sweating, dizziness, and confusion. Other possible effects include weight gain, nausea, and skin reactions. It is important to monitor blood sugar levels regularly while taking this medication.

Glibenclamide should be handled with care, especially by individuals with a history of liver or kidney problems. It is important to follow the prescribed dosage and to be aware of the signs of hypoglycemia. This medication should not be taken by individuals with type 1 diabetes or diabetic ketoacidosis. Always consult a healthcare provider before starting or stopping any medication.

Glibenclamide may interact with other medications, including those used to treat infections, heart conditions, and mental health disorders. Alcohol can also interact with Glibenclamide, increasing the risk of hypoglycemia. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.